Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiroxostat vs allopurinol in gout with hyperuricemia
CTR20180239Phase 3Completed
- Sponsor
- Nanjing Huawei Pharmaceutical Technology Development
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiroxostat in gout, hyperuricemia, sponsored by Nanjing Huawei Pharmaceutical Technology Development. Started Mar 2018; status: completed.
02
Drugs
topiroxostat
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on CTR20180239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180239.